Delivering long-term sustainable value
We are focused on maximising value at all points of the investment cycle to deliver transformational treatments to patients, capture superior risk adjusted returns for shareholders and build long-term value for all stakeholders.
SYNC (LON)
87.90 GBX
Change +0.10 (+0.11%)
04 April 2025 at 06:42. Pricing delayed by 20 mins.
Unless stated all financials at 31 December 2024
£1.1bn
Net assets
179p
NAV per share
(4.9)%
NAV per share return in the year
£780m
Value of life science portfolio
(9.5)%
Return from life science portfolio in the year
£345m
Capital pool
Regulatory news
1 / 6